Fesobig 8 Tablet ER contains Fesoterodine Fumarate 8mg, an extended-release medication primarily used to treat overactive bladder symptoms such as urinary urgency, frequency, and urge incontinence. Fesoterodine belongs to the class of antimuscarinic agents, which work by blocking the muscarinic receptors in the bladder's smooth muscle, thereby reducing involuntary contractions and increasing bladder capacity. This helps patients gain better control over urination and reduces episodes of leakage. The extended-release formulation ensures a steady release of the active ingredient over time, providing sustained symptom relief with once-daily dosing, which enhances patient compliance. Fesobig 8 is typically prescribed for adults and should be taken as directed by a healthcare professional, usually once daily with or without food. Common side effects may include dry mouth, headache, constipation, and dizziness, but these are generally mild and transient. Patients with certain conditions such as urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or severe liver impairment should avoid using this medication. It is important to inform the doctor about any other medications being taken to prevent potential interactions. Overall, Fesobig 8 Tablet ER offers an effective treatment option for managing overactive bladder symptoms and improving quality of life.